Family Site
The content provided by this website is intended only for Australian healthcare professionals.
Please leave this site if you are not an Australian healthcare professional.
How Remsima® works
Remsima® mode of action 1
Remsima® contains the active substance called infliximab.
Infliximab is a monoclonal antibody that recognises and binds to tumour necrosis factor alpha (TNF-α), which is present at increased levels in some inflammatory diseases. By blocking TNF-alpha, infliximab reduces inflammation.
Reference
1. Remsima® Australian Product Information. https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2020-PI-02540-1&d=202103141016933&d=20221121172310101. Last accessed: Nov 2022.
Abbreviation
TNF-α: tumor necrosis factor alpha